We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ARI:JSEAfrican Rainbow Minerals Limited Analysis

Data as of 2026-03-16 - not real-time

ZAC 22,005.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at ZAc 22,005, comfortably below the 20‑day (ZAc 22,674) and 50‑day (ZAc 22,739) simple moving averages, while the 200‑day SMA sits at ZAc 19,261, indicating a short‑term bearish bias but a longer‑term neutral stance. RSI sits at 46.8, suggesting neither overbought nor oversold conditions, and the MACD histogram is negative, reinforcing the bearish momentum. Technical support at ZAc 20,475 provides a cushion, yet the price remains well under the resistance zone of ZAc 26,219.
Fundamentally, the company generates ZAc 11.66 bn of revenue with modest 6.3% growth, but margins are thin (gross margin –1.6%, operating margin –2.3%). A strong cash position of ZAc 9.09 bn versus ZAc 2.04 bn debt yields a net‑cash balance, and the dividend yield of 4.59% with an 8% payout ratio underscores sustainability. The DCF fair‑value estimate of roughly ZAc 36,500 implies about a 13% upside, while analysts rate the stock a “strong buy” with median price targets around ZAc 26,500.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and price below short‑term SMAs
  • Proximity to technical support at ZAc 20,475
  • Attractive dividend yield of 4.59% with low payout

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF‑based upside of ~13% and forward PE of 9.8x
  • Strong analyst consensus (strong buy) and median target ZAc 26,500
  • Sustained cash generation and dividend sustainability

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust net‑cash position and low debt‑to‑equity pressure
  • Long‑term growth prospects from diversified mining assets
  • Consistent dividend policy supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth6.30%
Profit Margin2.83%
P/E Ratio32.6
ROE0.86%
ROA-0.49%
Debt/Equity3.38
P/B Ratio77.2
Op. Cash FlowZAC5.1B
Free Cash FlowZAC-3487124992

Technical Analysis

TrendNeutral
RSI46.8
SupportZAC 20,475.00
ResistanceZAC 26,219.00
MA 20ZAC 22,673.85
MA 50ZAC 22,738.78
MA 200ZAC 19,261.30
MACDBearish
VolumeStable
Fear & Greed Index75.84

Valuation

Fair ValueZAC 36,561.49
Target PriceZAC 24,900.00
Upside/Downside13.16%
GradeUndervalued
TypeGrowth
Dividend Yield4.59%

Risk Assessment

Beta0.35
Volatility55.70%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.